Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Hungary- Participants:18–64 years · 65+ years
- Substances:HRS 9531
- Sponsor:Kailera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary258 clinical trials in Siofok, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
KAI-9531 in Adults With Obesity or Overweight and Diabetes
HungaryA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
HungaryA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
HungaryA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
HungaryStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
HungaryStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
HungaryStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
HungaryStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
HungaryStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
HungaryStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
HungaryLong-Term Safety Study of JNJ-77242113 in Children with Immune System Disorders
HungaryPhase 3 Study of Maridebart Cafraglutide versus Semaglutide as Add‑on to Metformin (± SGLT‑2 Inhibitor) in Adults with Type 2 Diabetes Not Controlled by Metformin
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic kidney disease (CKD) combined with hypertension management. Studies are evaluating combination therapies to potentially slow disease progression and improve patient outcomes.
Research aims to enhance understanding of combined treatment approaches for complex renal conditions.
Clinical investigations targeting Eosinophilic Chronic Rhinosinusitis with nasal polyps, particularly in patients with concurrent asthma. Studies focus on innovative biological treatments for severe cases.
Research explores targeted therapies for complex respiratory and nasal conditions.
Groundbreaking research on Acute Respiratory Distress Syndrome (ARDS) caused by pneumonia and other infections. Studies evaluate novel protein-based treatments alongside standard care protocols.
Investigation focuses on improving survival rates and treatment efficacy in severe respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.